Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-08-19

Clinical Trial Update: Paclitaxel (Albumin-bound) and Oxaliplatin for Advanced Hepatobiliary and Malignant Tumors [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial investigating paclitaxel (albumin-bound) in combination with oxaliplatin for advanced hepatobiliary and malignant tumors; current status is unkn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OXALIPLATIN (Oxaliplatin)
  • Paclitaxel (albumin-bound) (paclitaxel albumin-bound)

Snippet

Sponsor: Dong Wang | Conditions: Advanced Hepatobiliary and Malignant Tumors | Phase 2, Phase 3 | Status: UNKNOWN